Patents by Inventor Christoph Riegger

Christoph Riegger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10471041
    Abstract: Use of genistein for the treatment and prevention of dry eye syndrome or LKC and corresponding compositions containing it.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: November 12, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Kevin Prudence, Christoph Riegger, Wolfgang Schalch
  • Publication number: 20180333371
    Abstract: The combination of curcumin and resveratrol can prevent the microglia from participating in the inflammation pathway in the brain. Thus this combination can reduce/prevent inflammation in the brain secondary to conditions such as obesity, diabetes, injury, and infection. The combination can also reduce chronic pain.
    Type: Application
    Filed: December 7, 2016
    Publication date: November 22, 2018
    Inventors: Christopher Michael BUTT, Christoph RIEGGER, Kelly WYNALDA
  • Publication number: 20180133193
    Abstract: Use of genistein for the treatment and prevention of dry eye syndrome or LKC and corresponding compositions containing it.
    Type: Application
    Filed: January 8, 2018
    Publication date: May 17, 2018
    Inventors: Kevin PRUDENCE, Christoph RIEGGER, Wolfgang SCHALCH
  • Publication number: 20100120904
    Abstract: Use of genistein for the treatment and prevention of dry eye syndrome or LKC and corresponding compositions containing it.
    Type: Application
    Filed: April 1, 2008
    Publication date: May 13, 2010
    Inventors: Kevin Prudence, Christoph Riegger, Wolfgang Schalch
  • Patent number: 7635692
    Abstract: A composition, useful in the prevention of osteoporosis, wherein said composition comprises (a) least one isoflavone and/or isoflavone glycoside, preferably genistein and/or genistin; (b) at least one polyunsaturated fatty acid; (c) optionally vitamin D, and /or one or more derivatives thereof and/or vitamin K and/or one or more derivatives thereof; and (d) optionally adjuvants and excipients in quantities as required, preferably within the range of 0.1 to 20% by weight, based on the total weight of the composition. Dietary compositions and galenical forms made therefrom and the use of said compositions for preventing osteoporosis and stimulating osteogenesis in mammals.
    Type: Grant
    Filed: March 11, 2002
    Date of Patent: December 22, 2009
    Assignee: DSM IP Assets B.V.
    Inventors: Stephanie Krammer, Christoph Riegger, Manfred Schlachter, Peter Weber
  • Publication number: 20090209636
    Abstract: An apparatus for generating a data stream having a series of segments using data organized in subsequent data frames, a data frame having more important and less important data. It comprises a packetiser for packetising data from a data frame into the series of segments having a first segment and a second segment, where the packetiser is operative to packetise the data of the frame so that a starting point of the more important data coincides with a starting point of the first segment and an information block adder for adding a first information block to the first segment.
    Type: Application
    Filed: June 7, 2006
    Publication date: August 20, 2009
    Inventors: Daniel Raederstorff, Christoph Riegger, Frank Thielecke
  • Publication number: 20080152730
    Abstract: Novel purified extracts from Ligusticum species are obtained by submitting crude extracts from Ligusticum species, particularly from Ligusticum wallichii (chuanxiong) containing less than 50 wt.-% of ligustilide to rectification under specific conditions.
    Type: Application
    Filed: January 26, 2006
    Publication date: June 26, 2008
    Inventors: Ralf Proplesch, Christoph Riegger, Werner Simon, Swen Wolfram
  • Publication number: 20040082523
    Abstract: A composition, useful in the prevention of osteoporosis, wherein said composition comprises (a) least one isoflavone and/or isoflavone glycoside, preferably genistein and/or genistin; (b) at least one polyunsaturated fatty acid; (c) optionally vitamin D, and /or one or more derivatives thereof and /or vitamin K and/or one or more derivatives thereof; and (d) optionally adjuvants and excipients in quantities as required, preferably within the range of 0.1 to 20% by weight, based on the total weight of the composition. Dietary compositions and galenical forms made therefrom and the use of said compositions for preventing osteoporosis and stimulating osteogenesis in mammals.
    Type: Application
    Filed: September 11, 2003
    Publication date: April 29, 2004
    Inventors: Stephanie Krammer, Christoph Riegger, Manfred Schlachter, Peter Weber